Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 4 September 2027
- Last conf. stmt
- 21 August 2026
Harness Therapeutics Limited
- Incorporated
- 22 August 2018 (8 years)
- Previously known as
- Transine Therapeutics Limited (until 22 January 2024)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Takeda Pharmaceutical Company Limited
- Accounts type
- Small
- Region
- East of England
- Address
- Minerva Building (B250)Babraham Research CampusCambridgeCB22 3AT
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 15 January 2025
British,Canadian
Born January 1966 (60)
Director · Appointed 5 July 2021
British,Irish
Born January 1972 (54)
Director · Appointed 4 August 2020
Luxembourger
Born September 1982 (44)
Officer history (12 former)
31 July 2026
Resigned Fontoura, Paulo, Dr as Director
26 June 2026
Resigned Gu, Jiaping, Dr as Director
5 June 2025
15 April 2025
Appointed Gu, Jiaping, Dr as Director
15 April 2025
Resigned Gerson, Miles as Director
15 January 2025
3 January 2025
Resigned Karson, Meenu as Director
19 December 2024
19 December 2024
Resigned Berrigan, Sean as Secretary
16 September 2024
Appointed Fontoura, Paulo, Dr as Director
8 April 2024
Appointed Karson, Meenu as Director
1 January 2024
Appointed Berrigan, Sean as Secretary
13 December 2023
16 October 2023
Resigned Daniel, Margaret Mary as Secretary
20 April 2022
1 November 2021
Appointed Gerson, Miles as Director
1 November 2021
Resigned Woodman, Robbie, Dr as Director
5 July 2021
4 August 2020
21 February 2020
Resigned Gustincich, Stefano, Dr as Director
28 January 2020
Resigned Carninci, Piero, Dr as Director
28 January 2020
Appointed Woodman, Robbie, Dr as Director
10 December 2019
23 September 2019
Appointed Daniel, Margaret Mary as Secretary
3 September 2018
22 August 2018
Appointed Gustincich, Stefano, Dr as Director
22 August 2018
Appointed Carninci, Piero, Dr as Director
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 16 November 2023
Owns 25–50% of shares
Holds 75–100% of voting rights
Scottish Limited Partnership
Reg. no. Sl021984
Takeda Pharmaceutical Company Limited
Corporate entity · Notified 28 January 2020
Owns 25–50% of shares
Public Limited Company
Reg. no. 1200-01-077461
Former controllers (2)
4 August 2020
Ceased Piero Carninci — Owns 25–50% of shares
4 August 2020
Ceased Stefano Gustincich — Owns 25–50% of shares
Group structure 21 shown
Ownership group derived from the Companies House PSC register
DDF 2 FP GP LLP Holds 25–50% of voting rights
DDF 2 FP LP Has significant influence or control
DDF 2 GP LLP Holds 25–50% of voting rights
SV Bco I FP GP LLP Holds 25–50% of voting rights
SV Bco I FP LP Right to appoint and remove a person
SV Bco I GP LLP Holds 25–50% of voting rights
Serenza Therapeutics Ltd Owns 25–50% of shares
SV Health Managers LLP Holds 75–100% of voting rights
Dementia Discovery GP LP Has significant influence or control
Harness Therapeutics Limited This company Holds 75–100% of voting rights
Loqus23 Therapeutics Limited Owns 25–50% of shares
SV DDF Number 1 Limited Owns 75–100% of shares
Dementia Discovery General Partner LLP Holds 75–100% of voting rights
SV DDF Number 2 Limited Owns 75–100% of shares
SV7 (Imf) FP LP Has significant influence or control
SV7 (Imf) FP GP LLP Holds 25–50% of voting rights
SV7 (Imf) GP LLP Holds 25–50% of voting rights
Cellinta Ltd Owns 75–100% of shares
SV8 Bio FP GP LLP Holds 25–50% of voting rights
SV8 Biotech FP LP Part right to 75–100% of surplus assets
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 September 2026 | Change of share class name or designation | |||
| 7 September 2026 | Change of details for a person with significant control | |||
| 3 September 2026 | Statement of capital following an allotment of shares | |||
| 2 September 2026 | Confirmation statement with updates | 21 August 2026 | ||
| 11 August 2026 | Purchase of own shares |
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →